Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
12h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
13h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
15h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
22h agoBuffalo Potash Files Annual Information Form and New Technical Report
23h agoIonik Announces 30-Day Extension of Senior Debt Facility
Alto Neuroscience, Inc. logo

Alto Neuroscience, Inc.

About

21.22USD-0.32 -1.49%
Closed • Updated at 02:14 GMT+00:00
Market Cap$744.69M
Volume271.4K
Beta1.80
RSI39.89
Health TechnologyBiotechnology

Alto Neuroscience, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 15 2026
Alto Neuroscience CEO Amit Etkin, M.D., Ph.D. Receives Columbia University Transformational Research Award
May 13 2026
Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 4 2026
Alto Neuroscience Presents Phase 2a Data for ALTO-207 in Major Depressive Disorder at SOBP Annual Meeting
Apr 21 2026
Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression
Apr 1 2026
Alto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements

Community Chat

Ask AI

Try asking
6ix6ix